Search
Can a Simple Blood Test Measure Fracture Recovery?
A new UCSF-led study has identified a potential early blood-based indicator of long bone fracture healing, offering a powerful new avenue to track recovery and personalize care.The UCSF Breast Care Center
The UCSF Breast Care Center delivers integrated patient care from diagnosis through treatment and beyond at six locations across the Bay Area.Breast Cancer: The Latest Evidence-Based Screening, Diagnostic and Treatment Options
In this informative webinar, UCSF breast surgeon Shoko Emily Abe, MD, reviews current evidence informing breast cancer screening, diagnosis and treatmentLung Transplant Candidates: Shining a Light on UCSF’s Evaluation Process
In this short presentation, pulmonologist Jeffrey A. Golden, MD, describes how the specialists of the UCSF Lung Transplant Program work together to ensure their patients are likely to succeed, with a focus on factors that can make or break survival prospects.Living Donor Renal Transplant
In this narrated surgical video, Chris Friese, MD, performs a right laparoscopic donor nephrectomy.UCSF Health Reaches 20,000 Organ Transplants
UC San Francisco surgeons have performed the health system’s 20,000th solid organ transplant, making it just the third in the nation to reach that milestone.UCSF Lung Transplant Program Honored as Best in U.S.
UCSF Health’s Lung Transplant program has been awarded INTERLINK’s 2025 Chairman’s Award for Transplant Excellence as the top-performing lung transplant program in the nation.UCSF Health to Mark Thirty-Five Years of Heart Transplantation in 2024
In 2024, UC Health will celebrate 35 years of performing heart transplants. Since completing their first heart transplant in March 1989, UCSF surgeons have performed nearly 600, and along the way, the health system has become a recognized leader in treating heart failure and the sixth largest program for transplants in the nation.Alcohol-Associated Liver Disease Program
UCSF HEPATOLOGY AND LIVER TRANSPLANT SERVICES have established the Alcohol-Associated Liver Disease Program, expanding access to hepatology care and liver transplantation for a broader range of patients.UCSF Lung Transplant Clinic in Roseville
UCSF Lung Transplant Clinic in RosevilleAdvancing Transplant Medicine
University of California, San Francisco (UCSF) stands at the forefront of transplant medicine, offering comprehensive adult services through UCSF Health and pediatric care through UCSF Benioff Children’s HospitalsNovel Therapy Aims to Make Type 1 Diabetes Patients Insulin Free
UCSF providing laboratory-produced islet cell therapy as part of clinical trial for Type 1 diabetes patients.UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life
Hospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years LaterProminent Cardiac Surgeons Join UCSF’s Advanced Heart Failure Comprehensive Care Center
UC San Francisco’s Cardiovascular team is welcoming two highly regarded cardiac surgeons to its renowned program. The specialists will join the newly formed Advanced Heart Failure Comprehensive Care Center (AHF CCC).Virtual Monitoring for Lung Transplant Patients Aided by Home Spirometry Device
A new home spirometry kit combines a spirometer with a patient engagement platform to collect lung function data and symptoms remotely. This enables UCSF’s Lung Transplant team to remotely track patients with the goal of identifying both symptomatic and asymptomatic changes in lung function that may be the first sign of early chronic rejection.Advanced Heart Failure Comprehensive Care Center
The Advanced Heart Failure Comprehensive Care Center (AHF CCC) at UCSF offers coordinated and comprehensive care for heart failure patients.Living Kidney Donation
The UCSF Connie Frank Transplant Center continues to explore new options, such as advanced donation vouchers, to provide patients who have end-stage renal disease (ESRD) the opportunity for a living donor transplant.Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.Seizures Stopped, Speech Preserved After Rare Auditory Cortex Tumor is Removed: A UCSF Case Study
The extraordinary success was made possible through research on the neural mechanisms of speech by Edward Chang, MD, UCSF neurosurgeon and chair of the Department of Neurological Surgery, and an advanced phase 2 surgical evaluation by the UCSF Epilepsy Center team.Prenatal Enzyme Replacement Therapy for Lysosomal Storage Diseases
Pregnant patients with a diagnosed fetal lysosomal storage disease may have the opportunity to receive a promising treatment that could improve their babies’ health after birth.Robotically Assisted, Completely Minimally Invasive Whipple Surgery: Case Study With Video
Since performing San Francisco’s first pure robotically assisted Whipple procedure in 2022, UCSF surgeons continue to be on the forefront of this technology, regularly performing robotic Whipple surgeries (pancreatoduodenectomies) on select patients.Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?
Approximately 12,000 Americans are diagnosed each year with glioblastoma. Patients survive on average for just 15 months after their diagnosis, and new treatments are urgently needed.Improving Management and Treatment of Thyroid Cancer
UCSF’s Julie Ann Sosa, MD, co-led an international task force establishing new clinical guidelines for the management of differentiated thyroid cancer.‘Every Time I Relapsed, There Would Be a New Course of Therapy’
He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.